Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism (Q43764271)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Davies GF

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Khandelwal RL

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Wu L

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Juurlink BH

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Roesler WJ

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1071-1079

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

In vitro studies on the action of CS-045, a new antidiabetic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Mechanisms by which Thiazolidinediones Enhance Insulin Action

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Oleic acid promotes the activation and translocation of phosphatidate phosphohydrolase from the cytosol to particulate fractions of isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Isolation and characterization of the gene coding for cytosolic phosphoenolpyruvate carboxykinase (GTP) from the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Oxidation pathways for the intracellular probe 2',7'-dichlorofluorescein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Fatty acid activation of peroxisome proliferator-activated receptor (PPAR).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Troglitazone has a scavenging effect on reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Effect of troglitazone (Rezulin) on fructose 2,6-bisphosphate concentration and glucose metabolism in isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Glucocorticoids repress induction by thiazolidinediones, fibrates, and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Protein glycation and oxidative stress in diabetes mellitus and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Elevated Levels of Authentic Plasma Hydroperoxides in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Insulin signaling is inhibited by micromolar concentrations of H(2)O(2). Evidence for a role of H(2)O(2) in tumor necrosis factor alpha-mediated insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Antioxidant alpha-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

Antioxidant and redox regulation of gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900764-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(01)00764-X

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43764271&oldid=2103134710"